Remove Dermatology Remove Pharma Companies Remove Regulation
article thumbnail

Novartis probed by Swiss authorities over ‘unlawful’ patent use

pharmaphorum

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”

article thumbnail

Digital tools driving innovative clinical trials

pharmaphorum

We have also seen the regulators actively support the use of these hybrid decentralised research approaches. Importantly, they enable pharma to be more patient-centric and design trials that are more conducive to people’s lifestyles, giving participants choice on how they want to participate in a study. Novel digital endpoints.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Conversion Rate Optimization for Pharma: Boosting HCP & Patient Engagement

Pharma Marketing Network

But how can pharma brands optimize their digital assets while staying compliant with industry regulations? Imagine a pharma website as a digital waiting room. By refining user experience, messaging, and engagement strategies, pharma companies can increase prescription intent, patient adherence, and HCP interaction rates.

article thumbnail

BioSpace Movers & Shakers, Dec. 18

The Pharma Data

Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital. AB2 Bio – Swiss pharma company AB2 Bio Ltd. Immune Regulation – U.K.-based

article thumbnail

How digital pathways are changing healthcare

pharmaphorum

The company has also expanded the platform into similar inflammatory conditions in rheumatology, dermatology and oncology. And by joining up pharma and healthcare, these tools can create an ecosystem where the two sectors are working together to put the patient at the centre of care, he says. Regulation barriers.

Doctors 69
article thumbnail

Top 7 Pharma Industry Leaders in 2020 By the Numbers

Delveinsight

Pharmaceutical companies may deal in both generic and brand-name drugs as well as medical devices. They are governed by a number of rules and regulations that govern drug patenting, testing, safety, efficacy, and marketing. . billion followed by the other sectors such as Immunology, Hepatology, and Dermatology (USD 4.86

article thumbnail

Audience Engagement Strategies for Pharma Marketing: Boost HCP and Patient Interaction

Pharma Marketing Network

Introduction In the highly regulated pharmaceutical industry, audience engagement is more than just a marketing goalit is a necessity for building trust with healthcare professionals (HCPs) and patients. But how can pharma brands create meaningful connections in a digital landscape crowded with content?